Wake Forest University Health Sciences: Prostatic Neoplasms trials

The registry lists 27 Prostatic Neoplasms studies with Wake Forest University Health Sciences as lead sponsor. 1 are open to participants now and 12 have results posted.

Early Phase 1 2Phase 1 1Phase 2 13Phase 3 2No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Fatty Acid Synthase Inhibition in Castration Refractory Prostate CancerRecruitingNCT04337580Phase 2
• Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among SurvivorsCompletedNCT03935282Not applicableResults posted
• Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation TherapyCompletedNCT03496805Phase 2Results posted
• A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate CancerActive, not recruitingNCT03246347Phase 2Results posted
• Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryTerminatedNCT03152786Phase 2Results posted
• CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate CancerCompletedNCT01985828Not applicableResults posted
• Memantine Hydrochloride in Helping Cancer Survivors Stop SmokingCompletedNCT01535040Phase 2Results posted
• Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer PatientsCompletedNCT01434342Early Phase 1Results posted
• L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer SurvivorsCompletedNCT01105130Phase 2Results posted
• Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate CancerCompletedNCT01054079Phase 2Results posted
• Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone MetastasesTerminatedNCT00634582Phase 2Results posted
• Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate CancerCompletedNCT00499408Phase 2Results posted
• Soy Protein/Effexor Hormone Therapy for Prostate CancerTerminatedNCT00354432Phase 3Results posted
• Evaluating Return to Continence and Potency Following Radical ProstatectomyWithdrawnNCT05742334Not applicable
• Opioid-Free Pain Control Regimen Following Robotic Radical ProstatectomyTerminatedNCT05597878Phase 2/3
• Characterize Tumor Hypoxia by Magnetic Resonance ImagingWithdrawnNCT03987568Not applicable
• Effect of Treatment on Work Experience in Patients With Stage I-III Prostate CancerCompletedNCT03963739
• Adaptation of an eHealth (Web-application) Platform for Delivery of a Sedentary Behavior Intervention Among Prostate Cancer PatientsTerminatedNCT03740035
• Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate CancerCompletedNCT03122743
• Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer DiagnosisCompletedNCT02397629
• Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate BiopsyWithdrawnNCT02252978Phase 2
• Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHTTerminatedNCT01724619Early Phase 1
• Omega-3 Fatty Acids in Treating Patients With Advanced Prostate CancerWithdrawnNCT00996749Not applicable
• C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate CancerCompletedNCT00804245Phase 1
• Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00416533Phase 2
• Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate BiopsyCompletedNCT00373035
• Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate CancerCompletedNCT00345813Phase 2